TrialCancer research and treatment2023

Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis.

Ting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.